DVA

+ Watchlist + Portfolio

DaVita Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $177.27
52-Week Range: $101.00 – $247.49
Market Cap: $11.18B
P/E (TTM): 15.02
EPS (TTM): 11.67
Dividend Yield: —

Advanced Metrics

Price/Book: —
PEG Ratio: 0.55
Return on Equity: 88.48%
Return on Assets: 7.51%
Gross Margin: 32.36%
Operating Margin: 16.06%
Profit Margin: 6.05%
Current Ratio: 1.47
Debt/Equity: 12.42
Total Debt: $13.41B
Free Cash Flow: $1.04B
Revenue Growth: 5.20%
Earnings Growth: 55.80%
Enterprise Value: $25.74B

DVA Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$11.61B	$12.14B	$12.82B	$13.64B
Cost of Revenue	$8.21B	$8.32B	$8.60B	$9.24B
Gross Profit	$3.40B	$3.82B	$4.22B	$4.40B
Selling, General & Admin	$1.36B	$1.47B	$1.54B	$1.67B
Operating Expenses	$2.09B	$2.22B	$2.26B	$2.39B
Operating Income	$1.31B	$1.60B	$1.95B	$2.01B
EBITDA	$2.06B	$2.32B	$2.72B	$2.64B
Pretax Income	$966.28M	$1.18B	$1.53B	$1.35B
Income Tax	$198.09M	$220.12M	$279.66M	$293.11M
Net Income	$560.40M	$691.53M	$936.34M	$746.80M
Diluted EPS	5.85	7.42	10.73	9.84
Diluted Shares	95.83M	93.18M	87.27M	75.89M

DVA Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$244.09M	$380.06M	$794.93M	$676.44M
Receivables	$2.55B	$2.42B	$2.56B	$2.96B
Inventory	$109.12M	$143.10M	$134.56M	$160.63M
Current Assets	$3.16B	$3.14B	$3.75B	$4.06B
Total Assets	$16.93B	$16.89B	$17.29B	$17.48B
Current Liabilities	$2.62B	$2.64B	$2.97B	$3.14B
Long-Term Debt	$8.69B	$8.27B	$9.18B	$10.16B
Total Debt	$11.82B	$11.12B	$12.07B	$12.87B
Total Liabilities	$14.70B	$14.15B	$15.19B	$16.32B
Retained Earnings	$174.49M	$598.29M	$1.53B	-$328.43M
Shareholders' Equity	$712.33M	$1.06B	$121.12M	-$651.08M
Working Capital	$535.54M	$495.69M	$772.66M	$916.37M
Net Debt	$8.68B	$8.01B	$8.65B	$9.60B

DVA Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$1.56B	$2.06B	$2.02B	$1.89B
Capital Expenditure	-$603.43M	-$567.99M	-$555.44M	-$575.86M
Free Cash Flow	$961.14M	$1.49B	$1.47B	$1.31B
Depreciation & Amortisation	$732.60M	$745.44M	$723.86M	$715.35M
Stock-Based Compensation	$95.43M	$112.38M	$102.79M	$139.95M
Investing Cash Flow	-$630.35M	-$771.80M	-$771.43M	-$654.95M
Financing Cash Flow	-$1.12B	-$1.17B	-$816.94M	-$1.37B
Share Repurchases	-$802.23M	-$272.22M	-$1.39B	-$1.79B
Net Change in Cash	-$186.91M	$116.74M	$433.67M	-$143.23M

DVA Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$3.22B	$3.38B	$3.42B	$3.62B	$3.42B
Cost of Revenue	$2.24B	$2.26B	$2.33B	$2.41B	$2.34B
Gross Profit	$983.87M	$1.12B	$1.09B	$1.21B	$1.07B
Selling, General & Admin	$374.09M	$412.81M	$414.37M	$472.36M	$421.91M
Operating Expenses	$550.54M	$587.51M	$591.86M	$659.07M	$599.74M
Operating Income	$433.33M	$530.48M	$495.61M	$551.21M	$473.55M
EBITDA	$597.84M	$689.69M	$636.85M	$717.71M	$664.19M
Pretax Income	$286.33M	$368.93M	$308.80M	$382.76M	$341.23M
Income Tax	$54.12M	$93.71M	$68.55M	$76.73M	$66.20M
Net Income	$162.92M	$199.34M	$150.33M	$234.22M	$197.53M
Diluted EPS	2.00	2.58	2.04	3.29	2.87
Diluted Shares	81.28M	77.36M	73.77M	71.26M	68.88M

DVA Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$438.78M	$708.42M	$705.96M	$676.44M	$644.24M
Receivables	$2.76B	$3.00B	$2.99B	$2.96B	$3.01B
Inventory	$150.52M	$146.29M	$139.09M	$160.63M	$141.61M
Current Assets	$3.64B	$4.09B	$4.11B	$4.06B	$4.06B
Total Assets	$17.12B	$17.49B	$17.56B	$17.48B	$17.50B
Current Liabilities	$2.91B	$2.93B	$3.02B	$3.14B	$2.87B
Long-Term Debt	$9.56B	$10.08B	$10.18B	$10.16B	$10.51B
Total Debt	$12.32B	$12.82B	$12.78B	$12.87B	$13.22B
Total Liabilities	$15.46B	$15.94B	$16.22B	$16.32B	$16.45B
Retained Earnings	$1.70B	$1.90B	$2.05B	-$328.43M	-$179.24M
Shareholders' Equity	-$267.10M	-$369.63M	-$571.87M	-$651.08M	-$755.50M
Working Capital	$729.41M	$1.15B	$1.09B	$916.37M	$1.20B
Net Debt	$9.30B	$9.55B	$9.54B	$9.60B	$9.98B

DVA Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	$180.01M	$324.24M	$841.53M	$540.73M	$320.83M
Capital Expenditure	-$143.26M	-$121.09M	-$166.09M	-$145.43M	-$102.02M
Free Cash Flow	$36.75M	$203.15M	$675.44M	$395.30M	$218.81M
Depreciation & Amortisation	$176.45M	$174.70M	$177.49M	$186.70M	$177.83M
Stock-Based Compensation	$29.76M	$32.81M	$38.99M	$38.39M	$28.16M
Investing Cash Flow	-$162.14M	-$67.17M	-$262.52M	-$163.13M	-$139.09M
Financing Cash Flow	-$382.54M	$4.45M	-$582.16M	-$414.52M	-$213.34M
Share Repurchases	-$541.85M	-$452.25M	-$470.08M	-$328.83M	-$396.31M
Net Change in Cash	-$364.67M	$261.52M	-$3.16M	-$36.92M	-$31.60M

Market Snapshot

About

DaVita Inc. is one of the largest providers of kidney dialysis services in the United States, serving patients with chronic kidney failure and end-stage renal disease. The company operates kidney care centers, providing both in-center hemodialysis and peritoneal dialysis services, as well as home dialysis programs. DaVita's integrated kidney care approach includes nephrology services, vascular access management, and clinical research programs. The company also provides acute dialysis services in hospitals and operates international dialysis facilities in several countries. DaVita serves approximately 200,000 patients through its network of outpatient dialysis centers.